POLE and neurofibromatosis type 1: POLE variants, which were also present in 12 tumors (32%) in the sample and encode for the catalytic subunit of DNA polymerase epsilon, have not commonly been identified in prior meningioma genomic studies, but have been implicated in syndromes related to neurofibromatosis type 1 [21].